English | Español
Bree Gonzales | Nov 3, 2021

Anomaly raises $17 million in funding to help ‘remove that friction between providers and payers’
Press release submission | Oct 31, 2021

HOPSTEM completed 40 million USD series B financing, to develop safe, effective and affordable iPSC cell therapies for global patients

Press release submission | Oct 30, 2021

Akebia Announces Otsuka's Submission of Initial Marketing Authorization Application to the European Medicines Agency for Vadadustat for the Treatment of Patients with Anemia due to Chronic Kidney Disease

Press release submission | Oct 29, 2021

Banty's Dr. Richard Tytus Explains How to Have Successful Virtual Medicine Appointments with Patients

Press release submission | Oct 29, 2021

HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors
Bob Martin | Oct 29, 2021

American Foundation for Suicide Prevention to spend $6.44 million on research this year
Press release submission | Oct 28, 2021

New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting

Karla Florez | Oct 28, 2021

FirstNet partners with AT&T to launch program for first responders who 'put their lives on the line every day'

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’